"Breast Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the human BREAST.
| Descriptor ID |
D001943
|
| MeSH Number(s) |
C04.588.180 C17.800.090.500
|
| Concept/Terms |
Breast Neoplasms- Breast Neoplasms
- Breast Neoplasm
- Neoplasm, Breast
- Breast Tumors
- Breast Tumor
- Tumor, Breast
- Tumors, Breast
- Neoplasms, Breast
Breast Carcinoma- Breast Carcinoma
- Breast Carcinomas
- Carcinoma, Breast
- Carcinomas, Breast
Mammary Neoplasms, Human- Mammary Neoplasms, Human
- Human Mammary Neoplasm
- Human Mammary Neoplasms
- Neoplasm, Human Mammary
- Neoplasms, Human Mammary
- Mammary Neoplasm, Human
Breast Cancer- Breast Cancer
- Cancer, Breast
- Mammary Cancer
- Cancer, Mammary
- Cancers, Mammary
- Mammary Cancers
- Malignant Neoplasm of Breast
- Breast Malignant Neoplasm
- Breast Malignant Neoplasms
- Malignant Tumor of Breast
- Breast Malignant Tumor
- Breast Malignant Tumors
- Cancer of Breast
- Cancer of the Breast
|
Below are MeSH descriptors whose meaning is more general than "Breast Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Breast Neoplasms".
This graph shows the total number of publications written about "Breast Neoplasms" by people in this website by year, and whether "Breast Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 13 | 2 | 15 |
| 1997 | 21 | 4 | 25 |
| 1998 | 24 | 4 | 28 |
| 1999 | 17 | 1 | 18 |
| 2000 | 16 | 7 | 23 |
| 2001 | 16 | 5 | 21 |
| 2002 | 11 | 7 | 18 |
| 2003 | 34 | 9 | 43 |
| 2004 | 25 | 7 | 32 |
| 2005 | 55 | 5 | 60 |
| 2006 | 45 | 7 | 52 |
| 2007 | 36 | 3 | 39 |
| 2008 | 39 | 6 | 45 |
| 2009 | 49 | 11 | 60 |
| 2010 | 59 | 11 | 70 |
| 2011 | 53 | 12 | 65 |
| 2012 | 43 | 6 | 49 |
| 2013 | 62 | 15 | 77 |
| 2014 | 58 | 14 | 72 |
| 2015 | 91 | 9 | 100 |
| 2016 | 55 | 11 | 66 |
| 2017 | 66 | 8 | 74 |
| 2018 | 76 | 4 | 80 |
| 2019 | 56 | 8 | 64 |
| 2020 | 59 | 12 | 71 |
| 2021 | 65 | 4 | 69 |
| 2022 | 57 | 1 | 58 |
| 2023 | 56 | 3 | 59 |
| 2024 | 50 | 5 | 55 |
| 2025 | 53 | 3 | 56 |
| 2026 | 25 | 0 | 25 |
To return to the timeline,
click here.
Below are the most recent publications written about "Breast Neoplasms" by people in Profiles.
-
Examining the Role of the Social Vulnerability Index in the Association between Race/Ethnicity and Breast Cancer Outcomes. Cancer Epidemiol Biomarkers Prev. 2026 Aug 03; 35(8):1345-1357.
-
VEMORA: Vaginal Estrogen versus non-hormonal MOisturizer in women Receiving Aromatase inhibitors: a randomized, controlled trial. Breast Cancer Res Treat. 2026 Jul 30; 218(2).
-
Pattern of opioid prescriptions among patients with breast, lung, and colorectal cancer diagnosed with pre-existing chronic non-cancer pain. PLoS One. 2026; 21(7):e0352907.
-
Real-world efficacy and safety of CDK4/6 inhibitors plus endocrine therapy in HR+/HER2?-?metastatic breast cancer: a single-institution experience. J Egypt Natl Canc Inst. 2026 Jul 28; 38(1).
-
GALNT6 localization is associated with gland-forming architecture and morphological differentiation in luminal A breast cancer. Biochim Biophys Acta Gen Subj. 2026 Oct; 1870(10):130975.
-
Prediction of Anthracycline Benefit in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Early-Stage Breast Cancer by the MammaPrint 70-Gene Signature for Patients Enrolled in the FLEX Study. JCO Precis Oncol. 2026 Jun; 10(6):e2501285.
-
Rat somatic genome editing enables ER+ breast cancer modeling. Proc Natl Acad Sci U S A. 2026 Jun 30; 123(26):e2529653123.
-
The longitudinal effects of faith and meaning on quality of life in US women with breast cancer undergoing chemotherapy. Palliat Support Care. 2026 Jun 10; 24:e164.
-
Risk of malignancy after diagnosis of radial sclerosing lesion without atypia. Breast Cancer Res Treat. 2026 Jun 08; 217(2).
-
NF1 loss in estrogen receptor-positive breast cancer induces osteoclast formation and immunosuppression to promote bone metastasis. Cancer Lett. 2026 Sep 01; 655:218636.